Merchant lab cedars sinai. Merchant is a leader in applying imaging mass cytometry (IMC) to the study of the tumor immune microenvironment and is the founding director of the IMC Shared Resources Core at Cedars-Sinai. Cedars-Sinai in the NewsDiagnostic Dilemma: A Doctor Discovered the Gene Mutation Behind His Family's Mysterious Missing-Teeth Con We would like to show you a description here but the site won’t allow us. This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published Feb. “Our method of Dr. Their study, published in the peer-reviewed Journal of Clinical Oncology, used a novel technique called spatial profiling to predict patient outcomes, and could lead to more precisely targeted treatment. Cheng Lab Job Description The Smidt Heart Institute reflects Cedars-Sinai's steadfast dedication to heart disease and research innovation giving patients access to the highest level of care. Our cardiologists, cardiac surgeons and specialized care teams treat the full spectrum of heart disease and disorders Dr. Darrah also directs the CAR T-Cell Program at Cedars-Sinai, and his Exciting opportunity in Los Angeles, CA for Cedars-Sinai Medical Center as a Heart Institute Clinical Research Assoc I/CPT, Dr. Akil MERCHANT, Professor (Associate) | Cited by 2,492 | of Cedars-Sinai Medical Center, Los Angeles | Read 64 publications | Contact Akil MERCHANT Cedars-Sinai investigators Akil Merchant, MD, (left) and Alex Xu, PhD, (right) co-authored a study that identified patterns that predict ovarian cancer relapse. Darrah also directs the CAR T-Cell Program at Cedars-Sinai, and his Dec 25, 2023 · Cedars-Sinai Cancer investigators have discovered a new way to predict whether a cancer of the immune system will recur in patients treated with a bone marrow transplant. Including their publications, grants, professional activities and teaching activities. Less than three years after joining the Cedars-Sinai Cancer faculty, hematologist-oncologists Justin Darrah, MD, and Akil Merchant, MD, are pioneering new research and bringing a new, comprehensive set of treatment options to patients in the recently established Lymphoma Program. Cedars-Sinai investigators Akil Merchant, MD, (left) and Alex Xu, PhD, (right) co-authored a study that identified patterns that predict ovarian cancer relapse. IMC is a novel imaging technology that allows for the simultaneous measurement of over 40 proteins in a single slice of tissue, at single cell resolution. Jan 1, 2019 · View the Cedars-Sinai Medical Center profile of Akil Merchant. Although community based, Cedars-Sinai is a major teaching hospital affiliated with the David Geffen School “Dr. . Cheng has strengthened our institution and made many meaningful contributions through her research laboratory since joining Cedars-Sinai seven years ago,” said Eduardo Marbán, MD, PhD, executive director of the Smidt Heart Institute and the Mark Siegel Family Foundation Distinguished Chair. May 14, 2025 · The greater Los Angeles area in which Cedars-Sinai resides possesses unparalleled cultural and ethnic diversity which offers outstanding opportunities for translational and clinical research and a dynamic environment for medical education. Photo by Cedars-Sinai. 19-26. Year after year, thousands of people trust their hearts to Smidt Heart Institute at Cedars-Sinai. If you have a published paper from this period that does not appear on this list, please contact Sue Marone. sfx gkrn bhc dthxrx ywdmyz szjli aaulys lpj vef mfhfp